HealthcareServices

RNA Sequencing Services Market Forecast 2026–2035: How to Leverage Market Growth

March 2, 2026March 3, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the rna sequencing services market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the RNA Sequencing Services Market expected to reach by 2030?

The rna sequencing services market has seen swift growth over recent years. Its value is projected to increase from $3.99 billion in 2025 to $4.44 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.2%. The expansion observed historically can be linked to several factors, including a rise in genomic research funding, the proliferation of academic and government research endeavors, the increasing application of sequencing in fundamental biology studies, the decreasing expenses associated with sequencing technologies, and greater access to sequencing service providers.

The rna sequencing services market size is projected to experience robust expansion over the coming years. This market is anticipated to reach $6.38 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.5%. Several factors will drive this growth during the forecast period, including the increasing embrace of precision medicine approaches, a heightened need for transcriptomic data in diagnostics, an expansion of pharmaceutical research and development activities, the growing incorporation of AI-driven data analytics, and increased outsourcing of sequencing services. Key trends for the forecast period encompass a rising requirement for high-throughput transcriptomic analysis, the increasing uptake of NGS-based rna sequencing, the broadening of bioinformatics-integrated sequencing services, an escalating application of rna sequencing in clinical research, and an intensified emphasis on data accuracy and reproducibility.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14991&type=smp

What Drivers Are Driving Adoption Within The RNA Sequencing Services Market?

The increasing need for customized medical care significantly fuels the expansion of the RNA sequencing services market. Personalized medicine involves adapting medical treatments to specific individual characteristics, such as genetics or lifestyle, to optimize effectiveness and minimize adverse reactions. The rising demand for personalized medicine stems from its potential to deliver more effective therapies, advancements in genomics, the growing complexity of diseases, and regulatory backing. RNA sequencing services play a crucial role in identifying disease subtypes, discovering biomarkers, pinpointing therapeutic targets, predicting treatment responses, and monitoring disease progression and treatment outcomes. Personalized medicine approaches utilize RNA sequencing technologies to provide individualized and effective medications that target the unique molecular characteristics of each patient. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA (Food and Drug Administration) approved 16 novel personalized therapies for patients with rare diseases in 2023, which is an increase from six in 2022. The personalized treatments newly sanctioned for 2023 also comprised seven cancer drugs and three for other diseases and conditions. Thus, the escalating requirement for personalized medicine is driving the growth of the RNA sequencing services market moving forward.

How Is The RNA Sequencing Services Market Organized Into Various Segments?

The rna sequencing services market covered in this report is segmented –

1) By Type: Ribosomal RNA (rRNA), Transfer RNA (tRNA), Long non-coding RNA (lncRNA)

2) By Sequencing Method: Next Generation Sequencing Methods, Other Sequencing Methods

3) By Application Area: Research Purposes, Diagnostic Purposes

4) By End Users: Academic And Government Institutes And Research Centers, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Ribosomal RNA (rRNA): Total RRNA Sequencing, RRNA Depletion

2) By Transfer RNA (tRNA): TRNA Profiling, TRNA Sequencing

3) By Long Non-Coding RNA (lncRNA): lncRNA Profiling, lncRNA Sequencing

Which Trends Are Guiding The Evolution Of The RNA Sequencing Services Market?

Major companies operating in the RNA sequencing services market are increasingly focusing on automation, exemplified by the next-generation sequencing (NGS) assay, to mitigate potential human error and enhance the efficiency and accuracy of data generation and analysis. The RNA next-generation sequencing (RNA-seq) assay is recognized as a powerful tool in molecular biology and genomics for analyzing the transcriptome of a biological sample. For instance, in June 2023, Tempus, a US-based precision medicine technology company, launched its new standalone RNA next-generation sequencing assay, known as Tempus xR. This innovative assay, tailored for solid tumors, provides a comprehensive analysis of the entire transcriptome, highlighting clinically significant fusions in over 100 targeted genes, along with altered splicing for MET Exon 14 and EGFRvIII. Recognizing the importance of RNA sequencing data, Tempus has historically integrated both RNA and DNA sequencing into its standard xT broad-panel assay. Now, clients are offered the flexibility to order each test separately or simultaneously, with the option to augment xR with specific Tempus algorithmic tests. This offering is designed to serve physicians with a particular interest in RNA fusions or altered splicing, as well as providers, researchers, and biopharma companies seeking detailed RNA sequencing analysis of their existing samples.

Who Are The Prominent Global Companies Shaping The RNA Sequencing Services Market Landscape?

Major companies operating in the rna sequencing services market are Thermo Fisher Scientific Inc., Illumina Inc., Qiagen NV, BGI Genomics Co Ltd, Azenta Inc., Novogene Co Ltd, Genewiz Inc., Diagenode LLC, CD Genomics, CeGaT GmbH, Lexogen GmbH, BaseClear BV, Active Motif Inc., Microsynth AG, Genomax Technologies Pte Ltd, Creative Biogene, SeqMatic LLC, Genohub Inc., Otogenetics, LC Sciences, Admera Health, Arraystar Inc., IGA Technology, Yaazh Xenomics, Novaseq Services Ltd

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/rna-sequencing-services-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The RNA Sequencing Services Market?

North America was the largest region in the RNA sequencing services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rna sequencing services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized RNA Sequencing Services Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=14991&type=smp

Browse Through More Reports Similar to the Global RNA Sequencing Services Market 2026, By The Business Research Company

Genomics Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-services-global-market-report

Ngs Based Rna Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

Ribonucleic Acid Rna Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/ribonucleic-acid-rna-sequencing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795